Literature DB >> 21412066

Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?

Christoph A Fux, Sandra Baumann, Hansjakob Furrer, Nicolas J Mueller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21412066     DOI： 10.1097/QAD.0b013e32834544af

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

Review 1.  Protease inhibitor monotherapy: what is its role?

Authors:  Miriam Estébanez; Jose R Arribas
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

2.  Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.

Authors:  Andrea D Branch; Burc Barin; Adeeb Rahman; Peter Stock; Thomas D Schiano
Journal:  Liver Transpl       Date:  2013-12-12       Impact factor: 5.799

3.  Recommendations for evaluation and management of bone disease in HIV.

Authors:  Todd T Brown; Jennifer Hoy; Marco Borderi; Giovanni Guaraldi; Boris Renjifo; Fabio Vescini; Michael T Yin; William G Powderly
Journal:  Clin Infect Dis       Date:  2015-01-21       Impact factor: 9.079

4.  Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

Authors:  Hanna Nylén; Abiy Habtewold; Eyasu Makonnen; Getnet Yimer; Leif Bertilsson; Jürgen Burhenne; Ulf Diczfalusy; Eleni Aklillu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.